Lamifiban

DB20451ExperimentalSmall molecule

Lamifiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lamifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). Lamifiban has... Lamifiban has a monoisotopic molecular weight of 468.2 Da.

Formula / weight: C₂₄H₂₈N₄O₆ · 468.51 g/mol (avg)
Code names: RO 44-9883/000

Resolves to

Compound

UNII9XOE28082SCAS144412-49-7ChEMBLCHEMBL108111ChEBI177737

Structure

InChIKeyFPKOGTAFKSLZLD-FQEVSTJZSA-NSMILESNC(=N)C1=CC=C(C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC(CC1)OCC(O)=O

Targets

P08514ITGA2BP05106ITGB3

What you can answer from here — as of September 16, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lamifiban, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account